Kontakte:Errol Zhou (Mesye.)
Tel: plis 86-551-65523315
Mobile/WhatsApp: plis 86 17705606359
QQ:196299583
Skype:lucytoday@hotmail.com
Imèl:sales@homesunshinepharma.com
Ajoute:1002, Huanmao Bilding, No.105, Mengcheng Wout, Hefei Vil, 230061, Lachin

CAS NON: 1051375-16-6
Fòmil Molekilè: C20H19F2N3O5
Pwa Molekilè: 419.37900
EINECS NON: 809-888-1
MDL NON: MFCD20488027
Deskripsyon pwodwi:
Non pwodwi: GSK1349572 CAS NON: 1051375-16-6
Sinonim:
(4R, 12aS) -N- (2,4-difluorobenzyl) -7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido [1 [ GG] # 39;, 2': 4,5] pirazino [2,1-b] [1,3] oxazine-9-karboksamid;
S / GSK1349572;
2H-Pyrido [1', 2': 4,5] pirazino [2,1-b] [1,3] oxazine-9-karboksamid, N - [(2,4 -difluorophenyl) methyl] -3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4R, 12aS) -;
Chimik& Pwopriyete fizik:
Aparans: Blan solid jòn pal
Egzamen: ≥99.0%
Dansite: 1.53
Pwen fizyon: 188-192 ℃
Bouyi Point: 669.0 ± 55.0 ℃ (prevwa)
Flash Point: 358.4 ± 31.5 ℃
Presyon vapè: 0.0 ± 2.1 mmHg nan 25 ℃
Endèks Refraksyon: 1.650
Dolutegravir (DTG) se yon dwòg FDA apwouve pou tretman enfeksyon VIH. Dolutegravir se yon inibitè entegre. Li te ye tankou S / GSK1349572 oswa jis" 572" se dwòg la commercialisés kòm Tivicay pa GlaxoSmithKline (GSK). An fevriye 2013, Administrasyon Manje ak Medikaman te anonse ke li ta rapid tras pwosesis apwobasyon dolutegravir' Sou Out 13, 2013, dolutegravir te apwouve pa FDA an. 4 novanm 2013, Sante Kanada apwouve dolutegravir. Sou 16 janvye 2014, Tivicay te apwouve pa Komisyon Ewopeyen an pou itilize nan tout Inyon Ewopeyen an.
Si ou enterese nan pwodwi nou yo oswa ou gen nenpòt kesyon, tanpri ou lib pou kontakte nou!
Pwodwi anba patant yo ofri pou R& D objektif sèlman. Sepandan, responsablite final la manti sèlman ak achtè a.
Baj popilè: gsk1349572 cas 1051375-16-6, manifaktirè, founisè, faktori, achte, nan stock